The 2024 Global Medtech Contract Manufacturing Report

This in-depth report investigates the current trends in the fast-growing global medtech outsourcing industry, with an emphasis on Western Europe countries.

Here are some of our findings:

• The European and US outsourcing markets combined represent over half of the global CDMO industry. Europe is home to many smaller, localized players that offer world-renowned specialization across fragmented operations.
• US-headquartered CDMOs generate nearly half of the total revenue of Europe’s medtech CDMO market.
• In 2023, a near-record number of deals took place globally surrounding medtech CDMOs. Over half of these deals occurred across international borders between US, Asian, and European players, demonstrating increasing interest in geographic expansion.
• The end markets attracting the most deals are also the fastest growing medtech verticals, signaling that investors expect orthopedics, cardiovascular, and surgical segments to continue flourishing in the future.
• Despite a strenuous 2023 in the medtech industry, the global medical device outsourcing market reached $81.5B in 2023, experiencing an 11.4% YoY growth since 2022. 

What drove this success? And what does the future hold for this dynamic market?

Get the 2024 Global Medtech Contract Manufacturing Report for an overview of the current state of the CDMO medtech industry and insight into the market trends with a critical view of the opportunities and risks that lie ahead.